Mill Creek Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Mill Creek Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,438	Closed	-$200K	–	255
2025 Q3	$200K	Buy	+4,438	New	+$207K	﹤0.01%	266
2025 Q2	–	Sell	-4,705	Closed	-$287K	–	264
2025 Q1	$287K	Sell	4,705 -1,236	-21%	-$72K	0.01%	219
2024 Q4	$336K	Sell	5,941 -93	-2%	-$5.2K	0.01%	202
2024 Q3	$312K	Sell	6,034 -9,989	-62%	-$469K	0.01%	202
2024 Q2	$665K	Buy	16,023 +464	+3%	+$20.8K	0.02%	147
2024 Q1	$844K	Buy	15,559 +517	+3%	+$26.3K	0.02%	116
2023 Q4	$772K	Sell	15,042 -191	-1%	-$10K	0.02%	121
2023 Q3	$884K	Sell	15,233 -1,701	-10%	-$104K	0.03%	102
2023 Q2	$1.08M	Buy	16,934 +755	+5%	+$50.6K	0.04%	96
2023 Q1	$1.12M	Sell	16,179 -32	-0.2%	-$2.26K	0.04%	97
2022 Q4	$1.17M	Buy	+16,211	New	+$1.22M	0.05%	87

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mill Creek Capital Advisors's BMY Position: Q4 2025 in Review

Mill Creek Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 4,438 shares — an estimated $200K sold.

Mill Creek Capital Advisors first reported a position in BMY in Q4 2022 and held it in 11 quarters. The position peaked at $1.17M in Q4 2022. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Mill Creek Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Mill Creek Capital Advisors sold 4,438 Bristol-Myers Squibb shares in Q4 2025, an estimated $200K.
Mill Creek Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 11 quarters.
Mill Creek Capital Advisors's Bristol-Myers Squibb position peaked at $1.17M in Q4 2022.
2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Mill Creek Capital Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.